Home›Companies›Biotech & Pharma›Seren Bio

Seren Bio Corp.

Updated Oct 27, 2026·Latest SEC filing Feb 12, 2024·Suggest an edit

About Seren Bio

Seren Bio is a private company based in Encinitas, California, incorporated in 2023 in Delaware. It has reported $55,000 raised in one offering on Form D since February 2024. Its chief executive is George Bonaros.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 22, 2024Feb 12, 2024$55,000of $490K target2$27,500Equity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Seren Bio's Form D filed Feb 12, 2024.

GB
George Bonaros
CEO and director
JL
Jongdae Lee
Executive officer and director

Sources

  1. SECSeren Bio Corp. filing history